Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma

• Zafar Zafari ,

  * E-mail: zafar.zafari@ubc.ca

  Affiliations Institute for Heart and Lung Health (IHLH), Faculty of Medicine, University of British Columbia, Vancouver, Canada, Center for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Institute, University of British Columbia, Vancouver, Canada

  ⨯
• Mohsen Sadatsafavi,

  Affiliations Institute for Heart and Lung Health (IHLH), Faculty of Medicine, University of British Columbia, Vancouver, Canada, Center for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Institute, University of British Columbia, Vancouver, Canada, Respiratory Medicine Division, Faculty of Medicine, University of British Columbia, Vancouver, Canada

  ⨯
• Carlo A. Marra,

  Affiliation School of Pharmacy, Memorial University of Newfoundland, St. John's, Canada

  ⨯
• Wenjia Chen,

  Affiliation Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

  ⨯
• J. Mark FitzGerald

  Affiliations Institute for Heart and Lung Health (IHLH), Faculty of Medicine, University of British Columbia, Vancouver, Canada, Center for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Institute, University of British Columbia, Vancouver, Canada, Respiratory Medicine Division, Faculty of Medicine, University of British Columbia, Vancouver, Canada

  ⨯